BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30631350)

  • 21. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium.
    Sedlacek L; Graf B; Schwarz C; Albert F; Peter S; Würstl B; Wagner S; Klotz M; Becker A; Haase G; Laniado G; Kahl B; Suerbaum S; Seibold M; Tintelnot K
    J Cyst Fibros; 2015 Mar; 14(2):237-41. PubMed ID: 25595044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy.
    Stewart AG; Heney C; Paterson DL; Harris PNA; Edwards F; Laupland KB
    Intern Med J; 2023 Aug; 53(8):1489-1491. PubMed ID: 37599232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumonia With Scedosporium apiospermum and Lomentospora prolificans in a Patient After Bilateral Lung Transplantation for Pulmonary Hypertension: A Case Report.
    Suzuki Y; Oishi H; Matsuda Y; Noda M; Kumata S; Hayasaka K; Okada Y
    Transplant Proc; 2021 May; 53(4):1375-1378. PubMed ID: 33707042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclophilin and enolase are the most prevalent conidial antigens of Lomentospora prolificans recognized by healthy human salivary IgA and cross-react with Aspergillus fumigatus.
    Buldain I; Ramirez-Garcia A; Pellon A; Antoran A; Sevilla MJ; Rementeria A; Hernando FL
    Proteomics Clin Appl; 2016 Oct; 10(9-10):1058-1067. PubMed ID: 27485921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.
    Seidel D; Hassler A; Salmanton-García J; Koehler P; Mellinghoff SC; Carlesse F; Cheng MP; Falces-Romero I; Herbrecht R; Jover Sáenz A; Klimko N; Mareş M; Lass-Flörl C; Soler-Palacín P; Wisplinghoff H; Cornely OA; Pana Z; Lehrnbecher T
    Int J Infect Dis; 2020 Mar; 92():114-122. PubMed ID: 31863876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface properties, adhesion and biofilm formation on different surfaces by
    Mello TP; Oliveira SSC; Frasés S; Branquinha MH; Santos ALS
    Biofouling; 2018 Aug; 34(7):800-814. PubMed ID: 30354689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope
    Seidel D; Meißner A; Lackner M; Piepenbrock E; Salmanton-García J; Stecher M; Mellinghoff S; Hamprecht A; Durán Graeff L; Köhler P; Cheng MP; Denis J; Chedotal I; Chander J; Pakstis DL; Los-Arcos I; Slavin M; Montagna MT; Caggiano G; Mares M; Trauth J; Aurbach U; Vehreschild MJGT; Vehreschild JJ; Duarte RF; Herbrecht R; Wisplinghoff H; Cornely OA
    Crit Rev Microbiol; 2019 Feb; 45(1):1-21. PubMed ID: 30628529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa Inhibits the Growth of Scedosporium and Lomentospora In Vitro.
    Chen SC; Patel S; Meyer W; Chapman B; Yu H; Byth K; Middleton PG; Nevalainen H; Sorrell TC
    Mycopathologia; 2018 Feb; 183(1):251-261. PubMed ID: 28512704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of Humoral Responses against
    Buldain I; Pellon A; Zaldibar B; Antoran A; Martin-Souto L; Aparicio-Fernandez L; Areitio M; Mayayo E; Rementeria A; Hernando FL; Ramirez-Garcia A
    Vaccines (Basel); 2019 Dec; 7(4):. PubMed ID: 31835471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
    Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
    J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scedosporium and Lomentospora Infections Are Infrequent, Difficult to Diagnose by Histology, and Highly Virulent.
    DeSimone MS; Crothers JW; Solomon IH; Laga AC
    Am J Clin Pathol; 2021 Nov; 156(6):1044-1057. PubMed ID: 34160012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying the emerging human pathogen Scedosporium prolificans by using a species-specific monoclonal antibody that binds to the melanin biosynthetic enzyme tetrahydroxynaphthalene reductase.
    Thornton CR; Ryder LS; Le Cocq K; Soanes DM
    Environ Microbiol; 2015 Apr; 17(4):1023-38. PubMed ID: 24684242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental Screening for the Scedosporium apiospermum Species Complex in Public Parks in Bangkok, Thailand.
    Luplertlop N; Pumeesat P; Muangkaew W; Wongsuk T; Alastruey-Izquierdo A
    PLoS One; 2016; 11(7):e0159869. PubMed ID: 27467209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active Cu(II), Mn(II) and Ag(I) 1,10-phenanthroline/1,10-phenanthroline-5,6-dione/dicarboxylate chelates: effects on
    Mello TP; Aor AC; Barcellos IC; Pereira MM; McCann M; Devereux M; Branquinha MH; Santos AL
    Future Microbiol; 2023 Nov; 18():1049-1059. PubMed ID: 37284767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp.
    Winn RM; Gil-Lamaignere C; Roilides E; Simitsopoulou M; Lyman CA; Maloukou A; Walsh TJ
    Cytokine; 2005 Jul; 31(1):1-8. PubMed ID: 15935692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report: Disseminated
    Bourlond B; Cipriano A; Regamey J; Papadimitriou-Olivgeris M; Kamani C; Seidel D; Lamoth F; Muller O; Yerly P
    Front Cardiovasc Med; 2022; 9():1045353. PubMed ID: 36386301
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of a
    Boan P; Pang S; Gardam DJ; Darragh H; Wright M; Coombs GW
    Med Mycol Case Rep; 2020 Sep; 29():1-4. PubMed ID: 32477857
    [No Abstract]   [Full Text] [Related]  

  • 38. Lomentospora prolificans endocarditis--case report and literature review.
    Kelly M; Stevens R; Konecny P
    BMC Infect Dis; 2016 Jan; 16():36. PubMed ID: 26822980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
    Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.
    Berenguer J; Rodríguez-Tudela JL; Richard C; Alvarez M; Sanz MA; Gaztelurrutia L; Ayats J; Martinez-Suarez JV
    Medicine (Baltimore); 1997 Jul; 76(4):256-65. PubMed ID: 9279332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.